Article info
PDFRecent advances in clinical practice
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
- Correspondence to Dr Scott A Waldman, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia PA 19107, USA; scott.waldman{at}jefferson.edu
Citation
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
Publication history
- Received January 19, 2018
- Revised February 19, 2018
- Accepted February 26, 2018
- First published March 21, 2018.
Online issue publication
December 22, 2018
Article Versions
- Previous version (22 December 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/